Cargando…

MALDI spectrometry for salivary samples analysis : a new tool for TTR amyloidosis diagnosis

Detalles Bibliográficos
Autores principales:	Seguier, Julie, Villard, Claude, Maysou, Laurie Anne, Habib, Gilbert, Verschueren, Annie, Belenotti, Pauilne, Lafitte, Daniel, Serratrice, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642104/ http://dx.doi.org/10.1186/1750-1172-10-S1-P46

Ejemplares similares

Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
por: Kapoor, Mahima, et al.
Publicado: (2019)

Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis
por: Iorio, Andrea, et al.
Publicado: (2017)

Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis
por: Bentellis, Imad, et al.
Publicado: (2019)

Non-invasive risk stratification of patients with TTR amyloidosis
por: Scherer, Katrin A, et al.
Publicado: (2013)

The phenotypical expression of an European inherited TTR amyloidosis in Brazil
por: Cruz, Márcia Waddington, et al.
Publicado: (2015)

TTR amyloidosis: a scientific journey since Andrade
por: Saraiva, Maria João
Publicado: (2015)

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
por: Niemietz, Christoph, et al.
Publicado: (2015)

Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis
por: Obici, Laura, et al.
Publicado: (2019)

Neuropathology of central nervous system involvement in TTR amyloidosis
por: Taipa, Ricardo, et al.
Publicado: (2022)

TTR Amyloidosis: Current State of Affairs and Promise for the Future
por: Brailovsky, Yevgeniy, et al.
Publicado: (2023)

SOM0226, a repositioned compound for the treatment of TTR amyloidosis
por: Reig, Núria, et al.
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis
por: Griffin, Jan M., et al.
Publicado: (2018)

TTR Gly83Arg Mutation: Beyond Familial Vitreous Amyloidosis
por: Li, Zhenxian, et al.
Publicado: (2022)

Cardiac Amyloidosis: A Rare TTR Mutation Found in an Asian Female
por: Mouksian, Kristina, et al.
Publicado: (2023)

MALDI Mass Spectrometry Imaging: A Novel Tool for the Identification and Classification of Amyloidosis
por: Winter, Martin, et al.
Publicado: (2017)

Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia
por: Ziskin, Jennifer L., et al.
Publicado: (2015)

Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases
por: González-Duarte, Alejandra, et al.
Publicado: (2018)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
por: Bemporad, Francesco, et al.
Publicado: (2022)

Acute pancreatitis and pneumonia due to Mycoplasma pneumoniae: a case report
por: Benzaquen, Michael, et al.
Publicado: (2016)

Uptake of Aggregating Transthyretin by Fat Body in a Drosophila Model for TTR-Associated Amyloidosis
por: Pokrzywa, Malgorzata, et al.
Publicado: (2010)

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise”
por: Grandis, Marina, et al.
Publicado: (2018)

Fatal TTR amyloidosis with neuropathy from domino liver p.Val71Ala transplant
por: Puffer, Ross C., et al.
Publicado: (2019)

Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis
por: Eze, Fredrick Nwude, et al.
Publicado: (2019)

Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction
por: Goland, Sorel, et al.
Publicado: (2021)

The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis
por: Moreira, João, et al.
Publicado: (2021)

Motor Conduction Studies and Handgrip in Hereditary TTR Amyloidosis: Simple Tools to Evaluate the Upper Limbs
por: Di Stefano, Vincenzo, et al.
Publicado: (2022)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry
por: Ploypetch, Sekkarin, et al.
Publicado: (2019)

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient
por: Seca, Mariana, et al.
Publicado: (2014)

Case Report: Vitreous Amyloidosis Caused by a TTR Lys55Asn Mutation With Intraoperative Suprachoroidal Hemorrhage
por: Xu, Qing, et al.
Publicado: (2022)

Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation
por: Bulinski, Catherine, et al.
Publicado: (2022)

Summation of Precordial R Wave Amplitudes, a Clinical Parameter for Detecting Early TTR Amyloidosis Cardiac Involvement
por: Isotani, Yoshitaka, et al.
Publicado: (2022)

Case Report: A rare homozygous patient affected by TTR systemic amyloidosis with a prominent heart involvement
por: Micaglio, Emanuele, et al.
Publicado: (2023)

Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
por: Adams, David, et al.
Publicado: (2015)

MALDI Mass Spectrometry Imaging Highlights Specific Metabolome and Lipidome Profiles in Salivary Gland Tumor Tissues
por: Sommella, Eduardo, et al.
Publicado: (2022)

Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
por: Yarlas, Aaron, et al.
Publicado: (2021)

Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: “In Vivo” Evidence from FAP Mice Models
por: Ferreira, Nelson, et al.
Publicado: (2012)

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
por: Brannagan, Thomas H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p8cub90689sa1t5lo8teg4rhq2